Literature DB >> 36152175

Measuring the Content of Endocannabinoid-Like Compounds in Biological Fluids: A Critical Overview of Sample Preparation Methodologies.

Heather B Bradshaw1, Clare T Johnson2.   

Abstract

Different mass spectrometric techniques have been used over the past decade to quantify endocannabinoids (eCBs) and related lipids. Even with the level of molecular fingerprinting accuracy of an instrument like the most advanced triple quadrupole mass spectrometer, if one is not getting the most optimized sample to the detector in a way that this improved technology can be of use, then advancements can be stymied. Here, our focus is on review and discussion of sample preparation methodologies used to isolate the eCB anandamide and its close congeners N-acyl ethanolamines and structural congeners (i.e., lipo amino acids, lipoamines, N-acyl amides) in biological fluids. Most of our focus will be on the analysis of these lipids in plasma/serum, but we will also discuss how the same techniques can be used for the analysis of saliva and breast milk.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acyl amino acids; Endocannabinoids; HPLC; Lipidomics; Lipoamino acids; Mass spectrometry; Solid phase extraction

Mesh:

Substances:

Year:  2023        PMID: 36152175     DOI: 10.1007/978-1-0716-2728-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  51 in total

Review 1.  Phosphatidylglycerols and lipoamino acids.

Authors:  M G Macfarlane
Journal:  Adv Lipid Res       Date:  1964

Review 2.  The expanding field of cannabimimetic and related lipid mediators.

Authors:  Heather B Bradshaw; J Michael Walker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 3.  Endocannabinoid Analytical Methodologies: Techniques That Drive Discoveries That Drive Techniques.

Authors:  Fabiana Piscitelli; Heather B Bradshaw
Journal:  Adv Pharmacol       Date:  2017-07-03

4.  N-arachidonoyl glycine, another endogenous agonist of GPR55.

Authors:  Linda Console-Bram; Sandra M Ciuciu; Pingwei Zhao; Robert E Zipkin; Eugen Brailoiu; Mary E Abood
Journal:  Biochem Biophys Res Commun       Date:  2017-07-08       Impact factor: 3.575

5.  N-Oleoylglycine-Induced Hyperphagia Is Associated with the Activation of Agouti-Related Protein (AgRP) Neuron by Cannabinoid Receptor Type 1 (CB1R).

Authors:  Junguo Wu; Canjun Zhu; Liusong Yang; Zhonggang Wang; Lina Wang; Songbo Wang; Ping Gao; Yongliang Zhang; Qingyan Jiang; Xiaotong Zhu; Gang Shu
Journal:  J Agric Food Chem       Date:  2017-01-30       Impact factor: 5.279

6.  Properties of lipoamino acids incorporated into membrane bilayers.

Authors:  R F Epand; M R Infante; T D Flanagan; R M Epand
Journal:  Biochim Biophys Acta       Date:  1998-08-14

7.  N-Docosahexaenoyl Dopamine, an Endocannabinoid-like Conjugate of Dopamine and the n-3 Fatty Acid Docosahexaenoic Acid, Attenuates Lipopolysaccharide-Induced Activation of Microglia and Macrophages via COX-2.

Authors:  Ya Wang; Pierluigi Plastina; Jean-Paul Vincken; Renate Jansen; Michiel Balvers; Jean Paul Ten Klooster; Harry Gruppen; Renger Witkamp; Jocelijn Meijerink
Journal:  ACS Chem Neurosci       Date:  2016-12-06       Impact factor: 4.418

8.  Lipoamino acid conjugates of methotrexate with antitumor activity.

Authors:  R Pignatello; G Jansen; I Kathmann; G Puglisi; I Toth
Journal:  J Pharm Sci       Date:  1998-03       Impact factor: 3.534

Review 9.  Novel endogenous N-acyl glycines identification and characterization.

Authors:  Heather B Bradshaw; Neta Rimmerman; Sherry S-J Hu; Sumner Burstein; J Michael Walker
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

10.  Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation.

Authors:  Siham Raboune; Jordyn M Stuart; Emma Leishman; Sara M Takacs; Brandon Rhodes; Arjun Basnet; Evan Jameyfield; Douglas McHugh; Theodore Widlanski; Heather B Bradshaw
Journal:  Front Cell Neurosci       Date:  2014-08-01       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.